...re Vaccine ected adverse events afte r hildhood Vaccine Injury Act 0OLD INFORM THE PM PROTECTION AGAINST DI P THE CHILD RECEIVING TH ',CUR, SUCH AS ANTIPY R li CARE PROVIDER . PARENT AS STATED IN THE NAsTION 'TANCE OF COMPLETING TH 1EACTIONS TO THEIR HEA L e immunization procedures . gulanttherapy. ale needle and syringe. ion with a pertussis-containing Raneously AM Oral Poliovim s re not available concerning th e I studies with TETRAMUNE di d arcinogenic mutagenic poles— - -MOM Obesity and Stature in Adolescenc e and Earnings in Young Adulthoo d Analysis of a British Birth Cohor t James D . Sargent, MD, David G . Blanchflower, PhD NE This product is not recomI been established. t Use (Td) is recommended. R e (DT) should be substituted in Ise) is based on a full course o f months of age in three separate on systemic symptoms within Objective: To examine the association between obe- sity and stature at various ages and earnings in young me n and women at age 23 years . Design : We estimated the effect of obesity on earnings xns Toddlers (107 doses) by constructing a series of ordinary least-squares regression equations in which the dependent variable was the natural logarithm of hourly earnings at age 23 years . We report the coefficients for obese subjects compared with those for the nonobese subjects and for height while con trolling for a number of other factors that are known t o affect pay . Setting : A birth cohort...
Words: 7087 - Pages: 29
...SU S AIN T ABI LI I M PA C T E EC ON OMIC S O CI A L & EN D R . R E D D Y ’ S L A B O R AT O R I E S L I M I T E D | A N N U A L R E P O R T | 2 0 0 9 – 1 0 RO VI V NM EN TA L • T Y • TI SI PO C R E AT I N G A C ONTENTS 24 MANAGEMENT DISCUSSION AND ANALYSIS 42 BOARD OF DIRECTORS 45 MANAGEMENT COUNCIL 72 DIRECTORS’ REPORT 2 CHAIRMAN’S LETTER 46 CORPORATE GOVERNANCE 89 IGAAP STANDALONE FINANCIALS 4 KEY HIGHLIGHTS 60 ADDITIONAL SHAREHOLDERS’ INFORMATION 70 FIVE YEARS AT A GLANCE 141 IGAAP CONSOLIDATED FINANCIALS 6 THE DNA OF SUSTAINABILITY 187 EXTRACT OF IFRS CONSOLIDATED FINANCIALS 190 STATEMENT PURSUANT TO SECTION 212 OF THE COMPANIES ACT, 1956 191 INFORMATION ON THE FINANCIALS OF SUBSIDIARY COMPANIES 192 NOTICE OF ANNUAL GENERAL MEETING 14 HUMAN RESOURCES 71 RATIO ANALYSIS 16 SAFETY, HEALTH AND ENVIRONMENT 18 CORPORATE SOCIAL RESPONSIBILITY 2 | S U S TA I N A B I L I T Y — C R E AT I N G A P O S I T I V E E C O N O M I C , S O C I A L A N D E N V I R O N M E N TA L I M PA C T CHAIRMAN’S LETTER 2009-10 has been a satisfactory year for your Company. Let me start with the financial results. Consolidated revenues for 2009-10 was Rs. 70,277 million. Excluding revenues from sumatriptan — your Company’s Authorized Generic version of Imitrex® which was launched in 2008-09 — revenue grew by 9%. In US dollar terms, 2009-10 revenue was US$ 1.56 billion. I am...
Words: 111729 - Pages: 447